[6-K] Haleon plc Current Report (Foreign Issuer)
Haleon plc reports its total issued share capital and voting rights as of 30 September 2025. The company has 8,952,353,648 ordinary shares of £0.01 each, of which 44,400,783 are held in treasury, leaving 8,907,952,865 ordinary shares with voting rights. Shareholders and others with notification obligations should use 8,907,952,865 as the denominator when assessing disclosure thresholds under the FCA's Transparency Rules. The filing provides a contact for notifiable interests (company.secretary@haleon.com) and a brief company description of Haleon’s consumer health business and major brands.
Haleon plc presenta il capitale sociale emesso totale e i diritti di voto al 30 settembre 2025. La società ha 8.952.353.648 azioni ordinarie da £0,01 ciascuna, delle quali 44.400.783 sono detenute in cassaforte, lasciando 8.907.952.865 azioni ordinarie con diritti di voto. Gli azionisti e altri obbligati alla notificazione dovrebbero utilizzare 8.907.952.865 come denominatore per valutare le soglie di disclosure secondo le Transparency Rules della FCA. La presentazione fornisce un contatto per interessi notificabili (company.secretary@haleon.com) e una breve descrizione aziendale dell’attività di consumo sanitario di Haleon e dei principali marchi.
Haleon plc informa de su capital social total emitido y de los derechos de voto al 30 de septiembre de 2025. La empresa tiene 8,952,353,648 acciones ordinarias de £0,01 cada una, de las cuales 44,400,783 están en tesorería, quedando 8,907,952,865 acciones ordinarias con derechos de voto. Los accionistas y otros con obligaciones de notificación deben usar 8,907,952,865 como denominador al evaluar los umbrales de divulgación bajo las Reglas de Transparencia de la FCA. El folleto proporciona un contacto para intereses notificables (company.secretary@haleon.com) y una breve descripción de la empresa de Haleon, su negocio de salud al consumidor y sus principales marcas.
Haleon plc는 2025년 9월 30일를 기준으로 발행 주식 총수와 의결권을 보고합니다. 회사는 8,952,353,648주의 보통주를 보유하고 있으며, 그 중 44,400,783주는 금고에 보관되어 있어 의결권이 있는 8,907,952,865주가 남습니다. FCA의 투명성 규칙에 따라 공시 임계치를 평가할 때 지수로 사용할 분모는 8,907,952,865주로 보셔야 합니다. 이 제출 자료에는 공시 대상 이익에 대한 연락처(company.secretary@haleon.com)와 Haleon의 소비자 건강 비즈니스 및 주요 브랜드에 대한 간략한 회사 설명이 포함되어 있습니다.
Haleon plc publie son capital social émis total et ses droits de vote au 30 septembre 2025. La société compte 8 952 353 648 actions ordinaires de £0,01 chacune, dont 44 400 783 sont en trésorerie, laissant 8 907 952 865 actions ordinaires avec droits de vote. Les actionnaires et autres personnes soumises à des obligations de notification doivent utiliser 8 907 952 865 comme dénominateur lors de l’évaluation des seuils de divulgation en vertu des règles de transparence de la FCA. Le dossier fournit un contact pour les intérêts notifiables (company.secretary@haleon.com) et une brève description de l’activité de santé grand public de Haleon et de ses grandes marques.
Haleon plc berichtet über das insgesamt ausgegebene Kapital und die Stimmrechte zum 30. September 2025. Das Unternehmen hat 8.952.353.648 Stammaktien im Nennwert von £0,01, von denen 44.400.783 im Treasury gehalten werden, wodurch 8.907.952.865 Stammaktien mit Stimmrechten verbleiben. Aktionäre und andere mit Offenlegungsverpflichtungen sollten 8.907.952.865 als Nenner bei der Bewertung von Offenlegungsschwellen gemäß den Transparenzregeln der FCA verwenden. Die Einreichung enthält eine Kontaktadresse für meldepflichtige Interessen (company.secretary@haleon.com) sowie eine kurze Beschreibung von Haleons Consumer-Health-Geschäft und den Hauptmarken.
Haleon plc تبلغ عن رأس المال المصدر الإجمالي وحقوق التصويت حتى 30 سبتمبر 2025. لدى الشركة 8,952,353,648 سهماً عاديًا بقيمة £0.01 للسهم، منها 44,400,783 مُخطّاة في الخزينة، تاركةً 8,907,952,865 سهماً عاديًا بحقوق التصويت. يجب على المساهمين وغيرهم من الأشخاص الخاضعين للالتزامات الإخطار استخدام 8,907,952,865 كمقام عند تقييم عتبات الإفصاح وفقًا لقواعد الشفافية الخاصة بـ FCA. يحتوي الملف على جهة اتصال للمصالح القابلة للإخطار (company.secretary@haleon.com) ووصف موجز لنشاط Haleon في صحة المستهلك والعلامات التجارية الرئيسية.
Haleon plc 报告截至2025年9月30日的总发行股本和表决权。公司拥有 8,952,353,648 股面值为 £0.01 的普通股，其中 44,400,783 股被 treasury 保留，剩余 8,907,952,865 股具有表决权。股东及其他有披露义务者在评估 FCA 透明度规则下的披露门槛时应使用 8,907,952,865 作为分母。该申报提供了可通知利益的联系方式（company.secretary@haleon.com）以及 Haleon 的消费者健康业务及主要品牌的简要公司描述。
- Exact issued share count provided: 8,952,353,648 ordinary shares reported
- Clear voting base specified for FCA notification calculations: 8,907,952,865 shares with voting rights
- Treasury shares disclosed: 44,400,783 held as treasury shares
- Contact provided for notifiable interests: company.secretary@haleon.com
- None.
Insights
TL;DR: A routine capital structure disclosure; provides exact share counts needed for ownership threshold calculations.
The report is a straightforward statement of issued shares and treasury holdings, giving the precise denominator (8,907,952,865) for FCA notification calculations. This is standard compliance reporting with no operational or financial data included. For analysts monitoring ownership changes, the filing eliminates ambiguity about the share base used for disclosure thresholds but does not affect valuation or operating performance.
TL;DR: Compliance-focused disclosure that ensures market transparency about voting rights and notification obligations.
The company confirms its issued share capital and treasury shares and supplies a contact for notifiable interests. This supports regulator and investor needs for clear share-count data when assessing significant shareholdings. There are no governance changes or director-related disclosures in this filing.
Haleon plc presenta il capitale sociale emesso totale e i diritti di voto al 30 settembre 2025. La società ha 8.952.353.648 azioni ordinarie da £0,01 ciascuna, delle quali 44.400.783 sono detenute in cassaforte, lasciando 8.907.952.865 azioni ordinarie con diritti di voto. Gli azionisti e altri obbligati alla notificazione dovrebbero utilizzare 8.907.952.865 come denominatore per valutare le soglie di disclosure secondo le Transparency Rules della FCA. La presentazione fornisce un contatto per interessi notificabili (company.secretary@haleon.com) e una breve descrizione aziendale dell’attività di consumo sanitario di Haleon e dei principali marchi.
Haleon plc informa de su capital social total emitido y de los derechos de voto al 30 de septiembre de 2025. La empresa tiene 8,952,353,648 acciones ordinarias de £0,01 cada una, de las cuales 44,400,783 están en tesorería, quedando 8,907,952,865 acciones ordinarias con derechos de voto. Los accionistas y otros con obligaciones de notificación deben usar 8,907,952,865 como denominador al evaluar los umbrales de divulgación bajo las Reglas de Transparencia de la FCA. El folleto proporciona un contacto para intereses notificables (company.secretary@haleon.com) y una breve descripción de la empresa de Haleon, su negocio de salud al consumidor y sus principales marcas.
Haleon plc는 2025년 9월 30일를 기준으로 발행 주식 총수와 의결권을 보고합니다. 회사는 8,952,353,648주의 보통주를 보유하고 있으며, 그 중 44,400,783주는 금고에 보관되어 있어 의결권이 있는 8,907,952,865주가 남습니다. FCA의 투명성 규칙에 따라 공시 임계치를 평가할 때 지수로 사용할 분모는 8,907,952,865주로 보셔야 합니다. 이 제출 자료에는 공시 대상 이익에 대한 연락처(company.secretary@haleon.com)와 Haleon의 소비자 건강 비즈니스 및 주요 브랜드에 대한 간략한 회사 설명이 포함되어 있습니다.
Haleon plc publie son capital social émis total et ses droits de vote au 30 septembre 2025. La société compte 8 952 353 648 actions ordinaires de £0,01 chacune, dont 44 400 783 sont en trésorerie, laissant 8 907 952 865 actions ordinaires avec droits de vote. Les actionnaires et autres personnes soumises à des obligations de notification doivent utiliser 8 907 952 865 comme dénominateur lors de l’évaluation des seuils de divulgation en vertu des règles de transparence de la FCA. Le dossier fournit un contact pour les intérêts notifiables (company.secretary@haleon.com) et une brève description de l’activité de santé grand public de Haleon et de ses grandes marques.
Haleon plc berichtet über das insgesamt ausgegebene Kapital und die Stimmrechte zum 30. September 2025. Das Unternehmen hat 8.952.353.648 Stammaktien im Nennwert von £0,01, von denen 44.400.783 im Treasury gehalten werden, wodurch 8.907.952.865 Stammaktien mit Stimmrechten verbleiben. Aktionäre und andere mit Offenlegungsverpflichtungen sollten 8.907.952.865 als Nenner bei der Bewertung von Offenlegungsschwellen gemäß den Transparenzregeln der FCA verwenden. Die Einreichung enthält eine Kontaktadresse für meldepflichtige Interessen (company.secretary@haleon.com) sowie eine kurze Beschreibung von Haleons Consumer-Health-Geschäft und den Hauptmarken.
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
|
Exhibit Number
|
Description
|
|
99.1
|
01
October 2025- “Total Voting Rights and
Capital”
|
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date: October 01,
2025
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|
FAQ
How many ordinary shares does Haleon plc (HLN) have issued?
What is the number of voting shares for HLN used to calculate FCA notification thresholds?
How many treasury shares does Haleon hold?
Who should be contacted to notify a notifiable interest in Haleon?
Does this 6-K include financial results or transaction details?
